
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Design, synthesis, and anti-proliferative evaluation of 1H-1,2,3-triazole grafted tetrahydro-β-carboline-chalcone/ferrocenylchalcone conjugates in estrogen responsive and triple negative breast cancer cells
Bharvi Sharma, Liang Gu, Ruvesh Pascal Pillay, et al.
New Journal of Chemistry (2020) Vol. 44, Iss. 26, pp. 11137-11147
Closed Access | Times Cited: 23
Bharvi Sharma, Liang Gu, Ruvesh Pascal Pillay, et al.
New Journal of Chemistry (2020) Vol. 44, Iss. 26, pp. 11137-11147
Closed Access | Times Cited: 23
Showing 23 citing articles:
1,2,3‐Triazole hybrids as anticancer agents: A review
Mohammad Mahboob Alam
Archiv der Pharmazie (2021) Vol. 355, Iss. 1
Closed Access | Times Cited: 205
Mohammad Mahboob Alam
Archiv der Pharmazie (2021) Vol. 355, Iss. 1
Closed Access | Times Cited: 205
Has Ferrocene Really Delivered Its Role in Accentuating the Bioactivity of Organic Scaffolds?
Bharvi Sharma, Vipan Kumar
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 23, pp. 16865-16921
Closed Access | Times Cited: 99
Bharvi Sharma, Vipan Kumar
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 23, pp. 16865-16921
Closed Access | Times Cited: 99
Application of triazoles in the structural modification of natural products
Hongyan Guo, Chen Zheng-ai, Qing‐Kun Shen, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 1115-1144
Open Access | Times Cited: 70
Hongyan Guo, Chen Zheng-ai, Qing‐Kun Shen, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 1115-1144
Open Access | Times Cited: 70
β-Carboline-based molecular hybrids as anticancer agents: a brief sketch
Jay Prakash Soni, Yogesh Yeole, Nagula Shankaraiah
RSC Medicinal Chemistry (2021) Vol. 12, Iss. 5, pp. 730-750
Open Access | Times Cited: 41
Jay Prakash Soni, Yogesh Yeole, Nagula Shankaraiah
RSC Medicinal Chemistry (2021) Vol. 12, Iss. 5, pp. 730-750
Open Access | Times Cited: 41
Recent advances in chalcone-triazole hybrids as potential pharmacological agents
Akanksha Bhukal, Vijay Kumar, Lokesh Kumar, et al.
Results in Chemistry (2023) Vol. 6, pp. 101173-101173
Open Access | Times Cited: 15
Akanksha Bhukal, Vijay Kumar, Lokesh Kumar, et al.
Results in Chemistry (2023) Vol. 6, pp. 101173-101173
Open Access | Times Cited: 15
Therapeutic potential of chalcone-1,2,3-triazole hybrids as anti-tumour agents: a systematic review and SAR studies
Sakshi Priya, Md. Shafiqul Islam, Shivani Kasana, et al.
Future Medicinal Chemistry (2025) Vol. 17, Iss. 4, pp. 449-465
Closed Access
Sakshi Priya, Md. Shafiqul Islam, Shivani Kasana, et al.
Future Medicinal Chemistry (2025) Vol. 17, Iss. 4, pp. 449-465
Closed Access
Recent Advances in Bioactive Flavonoid Hybrids Linked by 1,2,3-Triazole Ring Obtained by Click Chemistry
Daniela Pereira, Madalena Pinto, Marta Correia‐da‐Silva, et al.
Molecules (2021) Vol. 27, Iss. 1, pp. 230-230
Open Access | Times Cited: 39
Daniela Pereira, Madalena Pinto, Marta Correia‐da‐Silva, et al.
Molecules (2021) Vol. 27, Iss. 1, pp. 230-230
Open Access | Times Cited: 39
1,2,3-Triazole Derivatives with Anti-breast Cancer Potential
Xinyi Wu, Jun Wang, Shiqi Xia, et al.
Current Topics in Medicinal Chemistry (2022) Vol. 22, Iss. 17, pp. 1406-1425
Closed Access | Times Cited: 22
Xinyi Wu, Jun Wang, Shiqi Xia, et al.
Current Topics in Medicinal Chemistry (2022) Vol. 22, Iss. 17, pp. 1406-1425
Closed Access | Times Cited: 22
A brief survey on the application of metal-catalyzed azide–alkyne cycloaddition reactions to the synthesis of ferrocenyl-x-1,2,3-triazolyl-R (x = none or a linker and R = organic entity) compounds with anticancer activity
Konrad Kowalski
Coordination Chemistry Reviews (2022) Vol. 479, pp. 214996-214996
Closed Access | Times Cited: 19
Konrad Kowalski
Coordination Chemistry Reviews (2022) Vol. 479, pp. 214996-214996
Closed Access | Times Cited: 19
Current scenario of chalcone hybrids with antibreast cancer therapeutic applications
Huan Wang, Juanying Zhu, Qianru Zhang, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 5
Closed Access | Times Cited: 3
Huan Wang, Juanying Zhu, Qianru Zhang, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 5
Closed Access | Times Cited: 3
Click Chemistry in Natural Product Modification
Xiang Zhang, Shuning Zhang, Songfeng Zhao, et al.
Frontiers in Chemistry (2021) Vol. 9
Open Access | Times Cited: 26
Xiang Zhang, Shuning Zhang, Songfeng Zhao, et al.
Frontiers in Chemistry (2021) Vol. 9
Open Access | Times Cited: 26
Strategic application of CuAAC click chemistry in the modification of natural products for anticancer activity
Zaozao Xiao, Yuang Gu, Hewei Dong, et al.
European Journal of Medicinal Chemistry Reports (2023) Vol. 9, pp. 100113-100113
Open Access | Times Cited: 9
Zaozao Xiao, Yuang Gu, Hewei Dong, et al.
European Journal of Medicinal Chemistry Reports (2023) Vol. 9, pp. 100113-100113
Open Access | Times Cited: 9
Isatin-indoloquinoxaline click adducts with a potential to overcome platinum-based drug-resistance in ovarian cancer
Shefali Chowdhary, Asif Raza, Preeti Preeti, et al.
Bioorganic Chemistry (2023) Vol. 142, pp. 106953-106953
Closed Access | Times Cited: 7
Shefali Chowdhary, Asif Raza, Preeti Preeti, et al.
Bioorganic Chemistry (2023) Vol. 142, pp. 106953-106953
Closed Access | Times Cited: 7
Ferrocenyl Azoles: Versatile N‐Containing Heterocycles and their Anticancer Activities
Bhavya Deepthi Sadanala, Rajiv Trivedi
The Chemical Record (2024) Vol. 24, Iss. 7
Closed Access | Times Cited: 2
Bhavya Deepthi Sadanala, Rajiv Trivedi
The Chemical Record (2024) Vol. 24, Iss. 7
Closed Access | Times Cited: 2
Synthesis and Biological Evaluation of Harmirins, Novel Harmine–Coumarin Hybrids as Potential Anticancer Agents
Kristina Pavić, Maja Beus, Goran Poje, et al.
Molecules (2021) Vol. 26, Iss. 21, pp. 6490-6490
Open Access | Times Cited: 19
Kristina Pavić, Maja Beus, Goran Poje, et al.
Molecules (2021) Vol. 26, Iss. 21, pp. 6490-6490
Open Access | Times Cited: 19
The anti‐breast cancer therapeutic potential of 1,2,3‐triazole‐containing hybrids
Juntao Song, Shuai Zhang, Bo Zhang, et al.
Archiv der Pharmazie (2023) Vol. 357, Iss. 3
Closed Access | Times Cited: 6
Juntao Song, Shuai Zhang, Bo Zhang, et al.
Archiv der Pharmazie (2023) Vol. 357, Iss. 3
Closed Access | Times Cited: 6
Identification of mitochondrial ATP synthase as the cellular target of Ru-polypyridyl-β-carboline complexes by affinity-based protein profiling
Wenjin Wang, Yu-Yi Ling, Shi Yin, et al.
National Science Review (2024) Vol. 11, Iss. 8
Open Access | Times Cited: 1
Wenjin Wang, Yu-Yi Ling, Shi Yin, et al.
National Science Review (2024) Vol. 11, Iss. 8
Open Access | Times Cited: 1
Therapeutic significance of molecular hybrids for breast cancer research and treatment
Devendra Singh Negi, Irshad Ahmad
RSC Medicinal Chemistry (2022) Vol. 14, Iss. 2, pp. 218-238
Open Access | Times Cited: 7
Devendra Singh Negi, Irshad Ahmad
RSC Medicinal Chemistry (2022) Vol. 14, Iss. 2, pp. 218-238
Open Access | Times Cited: 7
Design, Synthesis, Antiproliferative Evaluation, and Molecular Docking Studies of N-(3-Hydroxyindole)-Appended β-Carbolines/Tetrahydro-β-Carbolines Targeting Triple-Negative and Non-Triple-Negative Breast Cancer
Bharvi Sharma, Sourav Saha, Shanen Perumal, et al.
ACS Omega (2020) Vol. 5, Iss. 45, pp. 28907-28917
Open Access | Times Cited: 9
Bharvi Sharma, Sourav Saha, Shanen Perumal, et al.
ACS Omega (2020) Vol. 5, Iss. 45, pp. 28907-28917
Open Access | Times Cited: 9
Synthesis of novel pyrrolidinyl chalcone derivatives: Spectral properties, energy band-gap tailoring, and amplified spontaneous emission
Amin O. Elzupir, K.H. Ibnaouf
Journal of Molecular Structure (2021) Vol. 1250, pp. 131698-131698
Closed Access | Times Cited: 9
Amin O. Elzupir, K.H. Ibnaouf
Journal of Molecular Structure (2021) Vol. 1250, pp. 131698-131698
Closed Access | Times Cited: 9
Tetrahydro-β-carboline-naphthalimide hybrids: Synthesis and anti-proliferative evaluation on estrogen-dependent and triple-negative breast cancer cells
Shalini Shalini, Shubham Lata, Sourav Saha, et al.
Journal of Molecular Structure (2022) Vol. 1262, pp. 133053-133053
Closed Access | Times Cited: 6
Shalini Shalini, Shubham Lata, Sourav Saha, et al.
Journal of Molecular Structure (2022) Vol. 1262, pp. 133053-133053
Closed Access | Times Cited: 6
Design and synthesis of ferrocene‐tethered pyrazolines and pyrazoles: Photophysical studies, protein‐binding behavior with bovine serum albumin, and antiproliferative activity against MDA‐MB‐231 triple negative breast cancer cells
Koena Ghosh, Nipa Nayek, Subhomoy Das, et al.
Applied Organometallic Chemistry (2021) Vol. 35, Iss. 7
Closed Access | Times Cited: 4
Koena Ghosh, Nipa Nayek, Subhomoy Das, et al.
Applied Organometallic Chemistry (2021) Vol. 35, Iss. 7
Closed Access | Times Cited: 4
New triazole-based coordination complexes as antitumor agents against triple negative breast cancer MDA-MB-468 cell line
Youssef Draoui, Smaail Radi, Yousra Bahjou, et al.
RSC Advances (2023) Vol. 13, Iss. 51, pp. 36158-36167
Open Access | Times Cited: 1
Youssef Draoui, Smaail Radi, Yousra Bahjou, et al.
RSC Advances (2023) Vol. 13, Iss. 51, pp. 36158-36167
Open Access | Times Cited: 1